Latest News

Karyopharm seeks FDA approval for drug in highly refractory blood cancer





Drugmaker applies for selinexor in penta-refractory multiple myeloma, in which bluebird’s bb2121 has also shown efficacy.



Source link




Related posts

MSU professor wins prestigious award for brain research

Newsemia

Medical News Today: What are the best lower chest exercises?

Newsemia

Lack of sexual activity in older adults linked to health problems

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy